News – Page 1144 – Endpoints News

Sanofi, Regeneron win a crucial stay of execution on Praluent

9 years ago

Bayer, J&J wrap positive PhIII cardio study for Xarelto early, looking to beef up its market

9 years ago

The next PARP M&A deal? Tesaro shares surge on latest buzz about a buyout

9 years ago

Lysogene raises $25M in Paris IPO; Chan Zuckerberg Biohub starts handing out $50M

9 years ago

After clearing an FDA hurdle, Amgen wins an FDA OK on CKD drug Parsabiv

9 years ago

Two friends and biotech colleagues with a passion for insider info - feds charge Merrimack staffer

9 years ago

As hep C revenue disintegrates, pressure keeps growing on Gilead to do deals

9 years ago

Lundbeck reads last rites on another failed PhIII Alzheimer’s program

9 years ago

White House: Trump remains committed to Medicare drug price negotiations

9 years ago

GW touts positive survival benefit in small brain cancer study; Ablynx files for ultra-rare disease drug OK

9 years ago

A swarm of top biotech execs protest against Trump’s travel ban, saying it threatens the entire industry

9 years ago

A better gene therapy vector out of Harvard is credited with restoring normal hearing in mice

9 years ago

Serono spinout grabs a $31M round for a pair of proof-of-concept Parkinson’s trials

9 years ago

As crisis deepens, Teva's board sees off CEO Erez Vigodman and an activist urges a split into two companies

9 years ago

Cellectis preps for groundbreaking US trials for an off-the-shelf CAR-T therapy

9 years ago

Chondrial bags a $22M A round for mitochondrial R&D; Ariad filed marketing app for brigatinib

9 years ago

Malin backs another microbiome upstart as Artizan breaks out of ‘covert’ role

9 years ago

With Trump’s new FDA commish nominee looming, industry execs are keeping their fingers crossed for Scott Gottlieb

9 years ago

LabCorp pursuing an $8B PPD buyout, tie up with Covance — report

9 years ago

Bristol-Myers partner Innate concedes a PhII flop for I/O drug lirilumab in fighting AML

9 years ago

After promising Trump new US jobs, Eli Lilly sets out to chop 200 R&D staffers

9 years ago

Stemline comes clean on patient death, but questions linger; Life sciences fund launches with €100M

9 years ago

Vowing to help, Trump manages to spark an angry protest against policies and a plan to revamp the FDA

9 years ago

Biotech dealmaker Ramaswamy raises another $55M for Axovant

9 years ago

First page Previous page 1141 1142 114311441145 1146 1147 Next page Last page